The hearing was originally scheduled for July, but Sen. Lamar Alexander, R-Tenn., chairman of the committee, delayed it when he became frustrated by Democratic senators using the June hearing to discuss the GOP’s ACA repeal efforts.
For the latest panel, Mr. Alexander has invited representatives from multiple pharmaceutical companies to discuss how drugs are manufactured and priced.
Mr. Alexander said he hopes the discussions cover everything from the “manufacturer’s development of a drug, the different steps through which the drug travels before arriving in the patient’s hands, how this is paid for and what the costs are at each of the different steps,” according to The Hill.
More Articles on Leadership:
Edward-Elmhurst Health to cut 200+ jobs
White House removes 15 Cuban diplomats following unknown ‘health attacks’
St. Francis to rebrand following U of Kansas Health System, Ardent takeover
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.